InsidersTradesSigma
Pharma Mar, S.A. Stock: price and insider trades · Spain · CNMV
Track the Pharma Mar, S.A. stock price and the full management transaction log of the company, a listed equity based in Spain. Shares are quoted on ES ES, under the oversight of CNMV. Operating in the Healthcare & Pharma sector, Pharma Mar, S.A. has logged 59 public disclosures. Market capitalisation: €1.4bn. The latest transaction was reported on 17 June 2026 (Other). Among the most active insiders: MONTSERRAT ANDRADE DETRELL. The full history is accessible without an account.
59
Insider Decl.
0
Thresholds
€2m
50 ops.
Buy Volume
€6,600
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Pharma Mar, S.A. Buy (bullish), based on 9 analysts. Average price target: €104.89.
36Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,229 of 25,936 companies
69.1
score / 100
Value48
Quality90
FCF yld3.1%
Earn yld5.3%
EV/EBITDA21.0x
ROE36%
Gross mgn94%
Net mgn34%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 June 2026
Declarations59 total
100 shares@ €93.450.0006% mcap3.0% of flowShareXMADCNMV:2026055309
Ideal exit: 16 Jan 2027 (T+270)
122 shares@ €81.570.0006% mcap100.0% of flowShareXOFFCNMV:2026048741
122 shares@ €81.570.0006% mcap100.0% of flowShareXOFFCNMV:2026048744
146 shares@ €81.570.0007% mcap100.0% of flowShareXMADCNMV:2026046976
Ideal exit: 21 Dec 2026 (T+270)
100 shares@ €81.000.0005% mcap16.3% of flowShareXMADCNMV:2026042671
Ideal exit: 18 Dec 2026 (T+270)
75 shares@ €88.000.0004% mcap13.3% of flowShareXMADCNMV:2026040871
75 shares@ €81.000.0004% mcap12.2% of flowShareXMADCNMV:2026038713
Ideal exit: 7 Dec 2026 (T+270)
70 shares@ €72.300.0003% mcap10.2% of flowShareXMADCNMV:2025138818
Ideal exit: 3 Aug 2026 (T+270)
100 shares@ €76.350.0005% mcap15.0% of flowShareXMADCNMV:2025132590
Ideal exit: 20 Jul 2026 (T+270)
500 shares@ €74.570.0022% mcap69.5% of flowShareXMADCNMV:2025130674
Ideal exit: 21 Jul 2026 (T+270)
215 shares@ €88.000.0011% mcap38.1% of flowShareXMADCNMV:2025124295
Ideal exit: 4 Jul 2026 (T+270)
62 shares@ €80.000.0003% mcap10.0% of flowShareXMADCNMV:2025118883
Ideal exit: 27 Dec 2025 (T+270)
100 shares@ €78.650.0005% mcap15.5% of flowShareXMADCNMV:2025084231
Ideal exit: 5 Oct 2025 (T+270)
100 shares@ €83.810.0005% mcap15.6% of flowShareXMADCNMV:2025078458
Ideal exit: 3 Mar 2026 (T+270)
100 shares@ €83.100.0005% mcap16.4% of flowShareXMADCNMV:2025078461
Ideal exit: 3 Mar 2026 (T+270)
100 shares@ €87.600.0005% mcap17.3% of flowShareXMADCNMV:2025077199
Ideal exit: 27 Feb 2026 (T+270)
90 shares@ €88.400.0005% mcap14.8% of flowShareXMADCNMV:2025072593
Ideal exit: 21 Dec 2025 (T+270)
2,402 shares@ €83.050.012% mcap100.0% of flowShareXMADCNMV:2025072213
Ideal exit: 14 Feb 2026 (T+270)
100 shares@ €74.200.0004% mcap14.6% of flowShareXMADCNMV:2025068237
Ideal exit: 3 Feb 2026 (T+270)
111 shares@ €70.750.0005% mcap5.3% of flowShareXMADCNMV:2025047967
Ideal exit: 2 Jan 2026 (T+270)
1,425 shares@ €69.950.0060% mcap46.4% of flowShareXMADCNMV:2025047966
Ideal exit: 2 Jan 2026 (T+270)
50 shares@ €82.200.0002% mcap8.1% of flowShareXMADCNMV:2025045462
Ideal exit: 27 Dec 2025 (T+270)
50 shares@ €88.900.0003% mcap8.8% of flowShareXMADCNMV:2025043092
Ideal exit: 21 Dec 2025 (T+270)
25 of 59 declarations
About Pharma Mar, S.A.
PHARMA MAR, S.A. is a Spanish biopharmaceutical company focused on the research and development of cancer treatments. It is listed on the Spanish stock market, XMAD.
